Accession Number: | 0000899243-21-009156 |
Date: | 2021-02-26 |
Issuer: | FORMA THERAPEUTICS HOLDINGS, INC. (FMTX) |
Original Submission Date: |
WADLINGER MARY E.
C/O FORMA THERAPEUTICS HOLDINGS, INC.
500 ARSENAL STREET, SUITE 100
WATERTOWN, MA 02472
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-02-26 | A | 14,300 | a | $0.00 | 129,875 | direct | ||
COMMON STOCK | 2021-02-26 | A | 9,330 | a | $0.00 | 139,205 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 38.61 | 2021-02-26 | deemed execution date | A | 43,550 (a) | 2031-02-25 | common stock 43,550 | $38.61 | 43,550 | direct |
ID | footnote |
---|---|
f1 | these shares represented restricted stock units and will be settled into common stock upon vesting. each restricted stock unit would be converted into one share of fmtx common stock. |
f2 | 25% of the shares subject to the stock option shall vest on february 22, 2022, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter. |